The Department of Biomedicine

News archive for The Department of Biomedicine

The partners in Medviz and the Molecular Imaging Centre (MIC) together aim to establish a large scale core facility, From Molecule to Man, for medical imaging in Bergen. The facility will comprise all relevant imaging modalities from molecular imaging to clinical scanners as well as all the relevant support functions and will have open access to all Norwegian researchers. It is now up to the NRC... Read more
There is a current imbalance between an auto-/semiautomated image acquisition processes and de facto manual image analysis. MIC, through a concerted effort with the UiB and BCCS, bioinformatics environment, aims to establish easy access and user support to state-of-the-art bioimaging software tools for (i) storage, (ii) retrieval, (iii) auto-mated analysis and (iv) visualization of the rapidly... Read more
After 25 years of research on integrins, the picture of how integrins have evolved is becoming clearer. At the same time, model organism will continue to offer valuable systems to elucidate the function of integrins in different tissues.
The mechanisms of cancer cell drug resistance is still not fully understood.
The Translational Signaling Group has through professor Stein Ove Døskeland expanded our contribution of selected articles by "The Faculty of 1000". These publications are resulting from ongoing collaboration with research groups in Denmark and Germany.
Professor Stein Ove Døskeland and his group of colleagues at the Department of Biomedicine, University of Bergen, is in the process of testing a new cancer medicine derived from bacteria found in seawater.
The Department of Biology (BIO), from MatNat Faculty and the Department of Biomedicine (BIOMED), from the Faculty of Medicine and Dentistry have undertaken a unique initiative that aims to optimize cutting edge research approaches and technology platforms at both Departments.
We study the circulation and fluid exchange in normal skin and muscle, kidney, heart, oral tissues and tumors. Our approach is integrative and translational using animal and cellular models for human disease.
In May 2009 the Biorecognition research group arrange their first internal seminar on Svalbard.